000 | 01831 a2200529 4500 | ||
---|---|---|---|
005 | 20250514164401.0 | ||
264 | 0 | _c20040206 | |
008 | 200402s 0 0 eng d | ||
022 | _a0002-9270 | ||
024 | 7 |
_a10.1111/j.1572-0241.2003.08723.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Rensburg, Christo J | |
245 | 0 | 0 |
_aIntragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. _h[electronic resource] |
260 |
_bThe American journal of gastroenterology _cDec 2003 |
||
300 |
_a2635-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xetiology |
650 | 0 | 4 | _aGastroscopy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOmeprazole _xanalogs & derivatives |
650 | 0 | 4 | _aPantoprazole |
650 | 0 | 4 |
_aPeptic Ulcer _xcomplications |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aSulfoxides _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHartmann, Manfred | |
700 | 1 | _aThorpe, Alida | |
700 | 1 | _aVenter, Louis | |
700 | 1 | _aTheron, Ilse | |
700 | 1 | _aLühmann, Reinhold | |
700 | 1 | _aWurst, Wilhelm | |
773 | 0 |
_tThe American journal of gastroenterology _gvol. 98 _gno. 12 _gp. 2635-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1572-0241.2003.08723.x _zAvailable from publisher's website |
999 |
_c14419216 _d14419216 |